Cargando…

Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression

Neuroinflammation has emerged as an important factor in the molecular underpinnings of major depressive disorder (MDD) pathophysiology and in the mechanism of action of antidepressants. Among the inflammatory mediators dysregulated in depressed patients, interleukin (IL)-6 has recently been proposed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossetti, Andrea C., Paladini, Maria Serena, Brüning, Cesar Augusto, Spero, Vittoria, Cattaneo, Maria Grazia, Racagni, Giorgio, Papp, Mariusz, Riva, Marco A., Molteni, Raffaella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604470/ https://www.ncbi.nlm.nih.gov/pubmed/36293308 http://dx.doi.org/10.3390/ijms232012453

Ejemplares similares

T221. LURASIDONE DISPLAYS ANTIDEPRESSANT AND PRO-COGNITIVE EFFECTS IN THE CHRONIC MILD STRESS MODEL: A ROLE FOR REDOX MECHANISMS AND PARVALBUMIN EXPRESSION
por: Rossetti, Andrea Carlo, et al.
Publicado: (2018)

Altered responsiveness of the antioxidant system in chronically stressed animals: modulation by chronic lurasidone treatment
por: Spero, Vittoria, et al.
Publicado: (2022)

Lurasidone Exerts Antidepressant Properties in the Chronic Mild Stress Model through the Regulation of Synaptic and Neuroplastic Mechanisms in the Rat Prefrontal Cortex
por: Luoni, Alessia, et al.
Publicado: (2015)

The Changes of Expression and Methylation of Genes Involved in Oxidative Stress in Course of Chronic Mild Stress and Antidepressant Therapy with Agomelatine
por: Wigner, Paulina, et al.
Publicado: (2020)

Chronic Mild Stress Modulates Activity-Dependent Transcription of BDNF in Rat Hippocampal Slices
por: Molteni, Raffaella, et al.
Publicado: (2016)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT
por: Dormegny-Jeanjean, Ludovic Christophe, et al.
Publicado: (2023)

Chronic Restraint Stress Inhibits the Response to a Second Hit in Adult Male Rats: A Role for BDNF Signaling
por: Brivio, Paola, et al.
Publicado: (2020)

Chronic Stress Exposure Reduces Parvalbumin Expression in the Rat Hippocampus through an Imbalance of Redox Mechanisms: Restorative Effect of the Antipsychotic Lurasidone
por: Rossetti, Andrea C, et al.
Publicado: (2018)

Prenatal Stress Impairs Spinal Cord Oligodendrocyte Maturation via BDNF Signaling in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
por: Paladini, Maria Serena, et al.
Publicado: (2020)

Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity
por: Calabrese, Francesca, et al.
Publicado: (2014)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

The effects of agomelatine and imipramine on liver cytochrome P450 during chronic mild stress (CMS) in the rat
por: Haduch, Anna, et al.
Publicado: (2020)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Publicado: (2014)

Differential Neuroinflammatory Response in Male and Female Mice: A Role for BDNF
por: Rossetti, Andrea Carlo, et al.
Publicado: (2019)

Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine
por: Musazzi, Laura, et al.
Publicado: (2014)

Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment
por: Calabrese, Francesca, et al.
Publicado: (2012)

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
por: Fornaro, Michele, et al.
Publicado: (2010)

Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes
por: Milanese, Marco, et al.
Publicado: (2013)

Cellular and molecular mechanisms in the long-term action of antidepressants.
por: Racagni, Giorgio, et al.
Publicado: (2008)

Agomelatine Changed the Expression and Methylation Status of Inflammatory Genes in Blood and Brain Structures of Male Wistar Rats after Chronic Mild Stress Procedure
por: Bialek, Katarzyna, et al.
Publicado: (2022)

The Impact of Chronic Mild Stress and Agomelatine Treatment on the Expression Level and Methylation Status of Genes Involved in Tryptophan Catabolic Pathway in PBMCs and Brain Structures
por: Wigner, Paulina, et al.
Publicado: (2020)

Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece
por: Maniadakis, Nikos, et al.
Publicado: (2013)

The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents
por: Fasipe, Olumuyiwa John
Publicado: (2019)

The Antidepressant Agomelatine Improves Memory Deterioration and Upregulates CREB and BDNF Gene Expression Levels in Unpredictable Chronic Mild Stress (UCMS)-Exposed Mice
por: Gumuslu, Esen, et al.
Publicado: (2014)

Altered inflammatory responsiveness in serotonin transporter mutant rats
por: Macchi, Flavia, et al.
Publicado: (2013)

Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants
por: Musazzi, Laura, et al.
Publicado: (2009)

Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?
por: Fornaro, Michele, et al.
Publicado: (2014)

Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents
por: Yang, Yang, et al.
Publicado: (2016)

Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats
por: Papp, Mariusz, et al.
Publicado: (2016)

Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression
por: Ventorp, Filip, et al.
Publicado: (2022)

Sucrose Preference Test as a Measure of Anhedonic Behavior in a Chronic Unpredictable Mild Stress Model of Depression: Outstanding Issues
por: Markov, Dmitrii D.
Publicado: (2022)

The Sweet Drive Test: refining phenotypic characterization of anhedonic behavior in rodents
por: Mateus-Pinheiro, António, et al.
Publicado: (2014)

Anhedonic Type Behavior and Anxiety Profile of Wistar-UIS Rats Subjected to Chronic Social Isolation
por: Acero-Castillo, María Camila, et al.
Publicado: (2021)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice
por: Cinque, C, et al.
Publicado: (2012)

A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
por: Pulcu, Erdem, et al.
Publicado: (2021)

Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress
por: Kim, Hye Ji J., et al.
Publicado: (2023)

Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT(2C )receptor-dependent pathways
por: Tardito, Daniela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cs387toq3n4e3hvtigqp892v28